Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Tuvusertib

Cat. No.: 0225LY-1290
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and HPLC.
Size:
Tuvusertib
Add to basket

Product Overview

Description: Tuvusertib is an orally available ATR kinase inhibitor that blocks CHK1 phosphorylation and disrupts DNA repair to induce apoptosis in tumor cells.
Synonym: M1774; ATR inhibitor 1; 1613200-51-3; M-1774; M 1774; 2-Amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide; 2-amino-6-fluoro-N-[5-fluoro-4-(3-methylimidazol-4-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide; compound I-C-79 (WO2014089379A1); 2-amino-6-fluoro-N-(5-fluoro-4-(1-methyl-1H-imidazol-5-yl)pyridin-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; 2-amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
CAS No.: 1613200-51-3
Compound CID: 90199447
Formula: C16H12F2N8
Formula Weight: 370.32

Specification

Relative Density: 1.68 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Tuvusertib can be used in DNA damage response research to study the potent and selective inhibition of ATR kinase.

Library Information

Target: Chk; ATM/ATR
Receptor: ATR; Chk1
Pathways: DNA damage/DNA repair; Apoptosis; PI3K/Akt/mTOR signaling; Cell cycle/Checkpoint
Plate Number: AOCL-17
Plate Location: e7
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 6.67 mg/mL; 18.01 mM
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.